Both in Biotechnology
Ginkgo Bioworks Holdings vs Attovia Therapeutics
Over the past year DNA returned +65.1% and ATTO returned −34.3%; their daily moves had a correlation of 0.47.
DNA +65.1% ATTO −34.3%Growth of $1, one year, split-adjusted
| Metric | DNA | ATTO |
|---|---|---|
| Price | $11.15 | $14.97 |
| Market cap | $750.5M | $683.4M |
| Today | +3.58% | −1.96% |
| 1 month | −10.2% | −14.5% |
| 6 months | +10.6% | — |
| Year to date | +34.1% | — |
| 1 year | −12.9% | — |
| Revenue growth (YoY) | −48.5% | — |
| Gross margin | 91.5% | — |
| Net margin | −231.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.7× | — |
| Net cash | $302.2M | — |
| Dividend yield | — | — |
| Volatility (60d) | 128.2% | — |
| Short % of float | 18.4% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).